Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1984 Mar 1;159(3):679–690. doi: 10.1084/jem.159.3.679

Studies of hematopoietic stem cells spared by 5-fluorouracil

PMCID: PMC2187260  PMID: 6699542

Abstract

Mouse marrow cells were exposed to 5-fluorouracil (FU) either in vivo or in vitro and the effects on the hematopoietic stem cell compartment were studied. The drug was highly toxic to bone marrow cells including the spleen colony-forming unit (CFU-S) population. The small population of stem cells surviving FU, however, caused a different pattern of spleen colony growth when injected into lethally irradiated mice. Whereas numbers of spleen colonies caused by normal marrow cells remained constant during an 8-14 d period after transplantation, spleen colonies derived from FU-treated marrow cells increased by as much as 100-fold during this time. This effect on stem cells was dose dependent both in vitro and in vivo. When FU was given in vivo, the day 14/day 8 ratio of colonies was greatest 1 d after injection and, over the next 7 d, returned to a near-normal value, that is, unity. A number of studies have shown that the stem cell compartment is heterogeneous with respect to self-replicative capacity and developmental potential. An age structure for the stem cell compartment has been proposed wherein cells with a short mitotic history are more likely to self-replicate than they are to differentiate; hence they are more primitive. 'Older' stem cells with a longer mitotic history are, according to the hypothesis, more likely to differentiate. 5-fluorouracil may be toxic to the older stem cells and selectively spare the more primitive subpopulation. Although the surviving cells may not themselves be able to form spleen colonies, they may give rise to an older cohort of cells more likely to differentiate and form spleen colonies. It is the requisite developmental maturation within the stem cell compartment that may be responsible for the delay in appearance of spleen colonies derived from FU-treated marrow. Our results support this explanation and identify the locus of at least part of this activity as the bone marrow. We found that the FU-treated marrow did not cause an increase in spleen colony numbers between 8 and 14 d in hosts with a long-standing marrow aplasia, due to the incorporation of 89Sr into bone. I propose that the delayed spleen colony appearance in normal hosts is the result of developmental maturation of the primitive stem cell compartment that survives FU and is responsible for spleen colonies arising around day 14. This maturation, at least initially, occurs in the marrow and leads to the replenishment of the more differentiated CFU-S subsets ablated by FU, which are normally responsible for spleen colonies appearing earlier after transplantation.

Full Text

The Full Text of this article is available as a PDF (735.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Curry J. L., Trentin J. J. Hemopoietic spleen colony studies. I. Growth and differentiation. Dev Biol. 1967 May;15(5):395–413. doi: 10.1016/0012-1606(67)90034-6. [DOI] [PubMed] [Google Scholar]
  2. Harrison D. E., Astle C. M., Delaittre J. A. Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather than aging. J Exp Med. 1978 May 1;147(5):1526–1531. doi: 10.1084/jem.147.5.1526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Harrison D. E. Long-term erythropoietic repopulating ability of old, young, and fetal stem cells. J Exp Med. 1983 May 1;157(5):1496–1504. doi: 10.1084/jem.157.5.1496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hellman S., Botnick L. E., Hannon E. C., Vigneulle R. M. Proliferative capacity of murine hematopoietic stem cells. Proc Natl Acad Sci U S A. 1978 Jan;75(1):490–494. doi: 10.1073/pnas.75.1.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hodgson G. S., Bradley T. R. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a pre-CFU-S cell? Nature. 1979 Oct 4;281(5730):381–382. doi: 10.1038/281381a0. [DOI] [PubMed] [Google Scholar]
  6. Humphries R. K., Eaves A. C., Eaves C. J. Characterization of a primitive erythropoietic progenitor found in mouse marrow before and after several weeks in culture. Blood. 1979 Apr;53(4):746–763. [PubMed] [Google Scholar]
  7. Klassen L. W., Birks J., Allen E., Gurney C. W. Experimental medullary aplasia. J Lab Clin Med. 1972 Jul;80(1):8–17. [PubMed] [Google Scholar]
  8. Magli M. C., Iscove N. N., Odartchenko N. Transient nature of early haematopoietic spleen colonies. Nature. 1982 Feb 11;295(5849):527–529. doi: 10.1038/295527a0. [DOI] [PubMed] [Google Scholar]
  9. Maloney M. A., Lamela R. A., Banda M. J., Patt H. M. Partitioning of bone marrow into stem cell regulatory domains. Proc Natl Acad Sci U S A. 1982 Feb;79(3):840–844. doi: 10.1073/pnas.79.3.840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ogawa M., Parmley R. T., Bank H. L., Spicer S. S. Human marrow erythropoiesis in culture. I. Characterization of methylcellulose colony assay. Blood. 1976 Sep;48(3):407–417. [PubMed] [Google Scholar]
  11. Radley J. M., Hodgson G. S., Levin J. Platelet production after administration of antiplatelet serum and 5-fluorouracil. Blood. 1980 Jan;55(1):164–166. [PubMed] [Google Scholar]
  12. Reissmann K. R., Samorapoompichit S. Effect of erythropoietin on regeneration of hematopoietic stem cells after 5-fluorouracil administration. J Lab Clin Med. 1969 Apr;73(4):544–550. [PubMed] [Google Scholar]
  13. Reissmann K. R., Udupa K. B., Okamura H. Effect of endotoxin on normal and 5-fluorouracil-suppressed hematopoietic stem cells. J Lab Clin Med. 1970 Oct;76(4):652–658. [PubMed] [Google Scholar]
  14. Rosendaal M., Dixon R., Panayi M. Haemopoietic stem cells: possibility of toxic effects of 5-fluorouracil on spleen colony formation. Blood Cells. 1981;7(3):561–574. [PubMed] [Google Scholar]
  15. Rosendaal M., Hodgson G. S., Bradley T. R. Organization of haemopoietic stem cells: the generation-age hypothesis. Cell Tissue Kinet. 1979 Jan;12(1):17–29. doi: 10.1111/j.1365-2184.1979.tb00110.x. [DOI] [PubMed] [Google Scholar]
  16. Ross E. A., Anderson N., Micklem H. S. Serial depletion and regeneration of the murine hematopoietic system. Implications for hematopoietic organization and the study of cellular aging. J Exp Med. 1982 Feb 1;155(2):432–444. doi: 10.1084/jem.155.2.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SIMINOVITCH L., TILL J. E., MCCULLOCH E. A. DECLINE IN COLONY-FORMING ABILITY OF MARROW CELLS SUBJECTED TO SERIAL TRANSPLANTATION INTO IRRADIATED MICE. J Cell Physiol. 1964 Aug;64:23–31. doi: 10.1002/jcp.1030640104. [DOI] [PubMed] [Google Scholar]
  18. Schofield R., Lord B. I., Kyffin S., Gilbert C. W. Self-maintenance capacity of CFU-S. J Cell Physiol. 1980 May;103(2):355–362. doi: 10.1002/jcp.1041030221. [DOI] [PubMed] [Google Scholar]
  19. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells. 1978;4(1-2):7–25. [PubMed] [Google Scholar]
  20. Van Zant G., Goldwasser E. Competition between erythropoietin and colony-stimulating factor for target cells in mouse marrow. Blood. 1979 May;53(5):946–965. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES